UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024253
Receipt number R000027925
Scientific Title The effect of Pectoral nerves block in breast cancer surgery; Randomized Controlled Trial
Date of disclosure of the study information 2016/10/03
Last modified on 2021/12/06 06:11:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of Pectoral nerves block in breast cancer surgery; Randomized Controlled Trial

Acronym

The effect of Pectoral nerves block in breast cancer surgery; Randomized Controlled Trial

Scientific Title

The effect of Pectoral nerves block in breast cancer surgery; Randomized Controlled Trial

Scientific Title:Acronym

The effect of Pectoral nerves block in breast cancer surgery; Randomized Controlled Trial

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare prospectively the quality of analgesia after mastectomy using general anesthesia and Pecs blocks versus general anesthesia alone.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Visual analog scale

Key secondary outcomes

Verbal Rating Scales
The short-form McGill Pain Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

US guided pectoral nerves block (pecs 1 block and pecs 2 block) preoperatively under general anesthesia

Interventions/Control_2

general anesthesia alone

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

99 years-old >=

Gender

Female

Key inclusion criteria

patients who undergo partial or radical mastectomy

Key exclusion criteria

patients who
#decline to give written informed consent,
#bilateral mastectomy,
#emergency or urgent case,
#history of allergy to the medications used in the study,
#contraindications to regional anesthesia (including coagulopathy and local infection),
#undergo concomitant breast reconstruction,
#dementia and psychiatric disorder
#Inhalation anesthesia

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Kunio
Middle name
Last name Kusajima

Organization

Teine Keijinkai Hospital

Division name

Department of Anesthesiology

Zip code

0060811

Address

1-40, 1-jo 12-chome, Maeda, Teine-ku, Sapporo, Hokkaido, Japan.

TEL

011-681-8111

Email

kunio555@gmail.com


Public contact

Name of contact person

1st name Kunio
Middle name
Last name Kusajima

Organization

Teine Keijinkai Hospital

Division name

Department of Anesthesiology

Zip code

0060811

Address

1-40, 1-jo 12-chome, Maeda, Teine-ku, Sapporo, Hokkaido, Japan.

TEL

011-681-8111

Homepage URL


Email

kunio555@gmail.com


Sponsor or person

Institute

Teine Keijinkai Hospital, Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization

Teine Keijinkai Hospital

Address

1-40, 1-jo 12-chome, Maeda, Teine-ku, Sapporo, Hokkaido, Japan.

Tel

011-681-8111

Email

nakahama@keijinkai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 30 Day

Date of IRB

2016 Year 10 Month 01 Day

Anticipated trial start date

2016 Year 10 Month 06 Day

Last follow-up date

2019 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 10 Month 02 Day

Last modified on

2021 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027925


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name